Clinical Trial Update: Re-Treatment Study of Probuphine in Opioid Addiction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for re-treatment with Probuphine in opioid dependency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Probuphine (buprenorphine implant)

Snippet

Sponsor: Titan Pharmaceuticals | Conditions: Opioid Dependency | Phase 3 | Status: COMPLETED